Diabetic retinopathy
Coronary heart disease
Care of the diabetic foot
      Heart failure  

 
Viewpoints
Revascularisation in coronary heart disease


Revascularisation procedures


Page 6 of 7:
Summary
The CHD and diabetes relationship
Early signs of CHD in people with diabetes
How is CHD detected?
What treatment options are available?
Revascularisation procedures
How do the procedures compare?
References

--Submenu:
 
  Percutaneous transluminal coronary angioplasty (PTCA)
  Coronary artery stenting
  Coronary artery bypass grafting (CABG)


Percutaneous transluminal coronary angioplasty (PTCA)
PTCA is a non-surgical procedure performed under X-ray guidance that can reduce a coronary arterial blockage from 70-90% to 20-30%. [Kern et al, 1997; Takeuchi and Himeno, 1998; Muller et al, 1990]. The patient is administered a mild sedative and a catheter with a deflated balloon mounted on the tip is inserted into the major vessel of the groin or arm under local anaesthetic. X-ray is used to guide the catheter up to the heart. In the middle of the balloon is a radiopaque marker, which is used to line up the balloon with the blockage.

The balloon is inflated using a small hand-held pump filled with dye. The balloon is inflated and deflated several times, squashing the atheromatous plaque. The inflation of the balloon is visualized on the X-ray until there is no dent in the balloon. The balloon is usually kept inflated for 1 to 2 minutes depending on the individual.

Complications and risks associated with this procedure are low but they do include:

severe bruising or bleeding into the groin area.
changes in heart rhythm.
allergic reaction to the dye.

a tear in the lining of the artery being unblocked.

blood clot in the artery into which the catheter is inserted.

myocardial infarction during inflation of the balloon (the patient is usually given blood thinning agents to reduce this risk).

Top of Page

Coronary artery stenting
A stent is a small tube made of wire mesh that may be used as an alternative to – or in combination with – PTCA. Stents act like scaffolding, holding the artery wall open and keeping the plaque from obstructing the flow of blood.

Stents are primarily used for preventing reocclusion after angioplasty, reducing the chance of reocclusion from 30% to 20%. [Kern et al, 1997; Takeuchi and Himeno, 1998; Muller et al, 1990] This is particularly important in people with diabetes who have a higher risk of reocclusion.

Intravascular ultrasound is used before stenting to visualise the full 360-degree circumference of the vessel wall, allowing measurement of the lumen dimensions.

View the following series as an animation

Figure 2.
Stents are put in place by being tightly mounted, collapsed, on the outside of an angioplasty balloon.


Enlarge


Figure 3.
The blockage has usually been treated with one or more angioplasty balloons before a stent is inserted. As with angioplasty, the balloon – with the stent surrounding it – is threaded along the ultra thin guide wire to the blockage.
Enlarge


Figure 4.
The balloon is expanded and as it expands the stent expands to the same diameter and locks into place.

Enlarge


Figure 5.
The balloon is then deflated and the balloon and wire are removed.

Enlarge


Figure 6.
Over time, the stent becomes a permanent structure with cells growing around and through it.

Enlarge

Complications of stenting are minimal but do occur. These complications can increase morbidity and mortality and include restenosis and thrombosis. In addition, rare stent complications can occur when the vessel is damaged or there is incomplete expansion of the stent.
Top of Page

Coronary artery bypass grafting (CABG)
CABG aims to reroute or bypass blood around an arterial blockage using a blood vessel taken from another part of the body. During the procedure, the patient is connected to a heart and lung machine allowing the heart to be stopped by the administration of specific drugs (cardioplegia) while the new vessel is grafted. The preparation of the heart is carried out simultaneously to the harvesting of the new vessel.

Until fairly recently the saphenous vein was always used, with one end connected to the aorta and the other to the coronary artery, below the blockage. However, it was then discovered that the internal mammary artery (also known as the internal thoracic artery) may also be used. It was also observed that this vein stays open longer than the saphenous vein. Now surgeons prefer to use this vessel whenever possible.

The indications for CABG include:

disease of the left main coronary artery.

disease of all three major coronary arteries.

abnormal function of the left ventricle.

However, this procedure may also be indicated in other specific circumstances and therefore every patient's situation should be considered. CABG is usually recommended when it is thought that no other procedure will give the same results. A calculation of the risk/benefit ratio must be carried out by the physician. Risks involved in CABG include bleeding, infection, stroke, kidney failure and myocardial infarction.
Top of Page

Next
Previous

 

 

 
Print this page
   
  Add to Favourites
   

Top of page | Home